Healthpeak Properties, Inc. $DOC Shares Sold by Adage Capital Partners GP L.L.C.

Key Points

• Adage Capital Partners GP L.L.C. reduced its stake in Healthpeak Properties by 2.3%, holding 638,443 shares valued at approximately $12.9 million after selling 15,000 shares.
• CEO Scott M. Brinker acquired 2,930 shares of Healthpeak Properties, increasing his ownership by 1.41%, bringing his total to 210,416 shares worth about $3.59 million.
• Recent research reports have led to varying price target adjustments for Healthpeak Properties, with Wells Fargo lowering its target from $20.00 to $18.00, while Morgan Stanley adjusted its target to $21.00, indicating a sentiment mix among analysts.

Adage Capital Partners GP L.L.C. lowered its holdings in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 2.3% in the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 638,443 shares of the real estate investment trust's stock after selling 15,000 shares during the period. Adage Capital Partners GP L.L.C. owned about 0.09% of Healthpeak Properties worth $12,909,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Invesco Ltd. boosted its holdings in Healthpeak Properties by 20.7% in the first quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust's stock valued at $467,311,000 after purchasing an additional 3,967,830 shares during the last quarter. Fuller & Thaler Asset Management Inc. boosted its holdings in Healthpeak Properties by 6.5% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 18,397,841 shares of the real estate investment trust's stock valued at $372,004,000 after purchasing an additional 1,129,924 shares during the last quarter. Centersquare Investment Management LLC boosted its holdings in Healthpeak Properties by 18.5% in the first quarter. Centersquare Investment Management LLC now owns 13,285,932 shares of the real estate investment trust's stock valued at $268,642,000 after purchasing an additional 2,070,416 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Healthpeak Properties by 0.7% in the first quarter. Dimensional Fund Advisors LP now owns 10,392,052 shares of the real estate investment trust's stock valued at $210,126,000 after purchasing an additional 76,978 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Healthpeak Properties by 0.8% in the first quarter. Charles Schwab Investment Management Inc. now owns 10,238,001 shares of the real estate investment trust's stock valued at $207,012,000 after purchasing an additional 84,551 shares during the last quarter. Hedge funds and other institutional investors own 93.57% of the company's stock.

Insider Buying and Selling at Healthpeak Properties

In related news, CEO Scott M. Brinker purchased 1,490 shares of the company's stock in a transaction dated Monday, August 4th. The shares were acquired at an average cost of $16.83 per share, for a total transaction of $25,076.70. Following the transaction, the chief executive officer owned 211,906 shares of the company's stock, valued at $3,566,377.98. This trade represents a 0.71% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In the last 90 days, insiders purchased 8,783 shares of company stock worth $150,129. 0.23% of the stock is currently owned by corporate insiders.

Healthpeak Properties Stock Performance

Shares of Healthpeak Properties stock traded down $0.04 on Friday, reaching $18.10. 4,343,202 shares of the company were exchanged, compared to its average volume of 6,111,745. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.28 and a current ratio of 1.28. The company's 50-day moving average is $17.76 and its two-hundred day moving average is $18.20. The firm has a market cap of $12.58 billion, a price-to-earnings ratio of 75.44, a P/E/G ratio of 2.33 and a beta of 1.07. Healthpeak Properties, Inc. has a 1-year low of $16.63 and a 1-year high of $23.26.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, hitting analysts' consensus estimates of $0.46. The business had revenue of $694.35 million for the quarter, compared to analysts' expectations of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.The business's quarterly revenue was down .2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, research analysts expect that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The business also recently declared a monthly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 18th were given a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a dividend yield of 6.7%. The ex-dividend date was Monday, August 18th. Healthpeak Properties's dividend payout ratio is presently 508.33%.

Wall Street Analyst Weigh In

DOC has been the subject of a number of analyst reports. Scotiabank downgraded Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and reduced their price target for the company from $21.00 to $19.00 in a report on Tuesday, July 29th. Wells Fargo & Company cut their price objective on Healthpeak Properties from $20.00 to $18.00 and set an "equal weight" rating on the stock in a research note on Wednesday, August 27th. Morgan Stanley cut their price objective on Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating on the stock in a research note on Friday, August 22nd. Deutsche Bank Aktiengesellschaft restated a "hold" rating and set a $18.00 price objective (down previously from $28.00) on shares of Healthpeak Properties in a research note on Wednesday, August 20th. Finally, Wall Street Zen cut Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Monday, July 7th. Seven analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $21.50.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.